Skip to content
10-K

Annual Report

ACADIA PHARMACEUTICALS INC ACAD

0001193125-26-072519

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 18, 2026 170.49M sh
Shares Diluted FY 2025 · Dec 31, 2025 169.92M sh
Shares Diluted FY 2025 · Dec 31, 2024 166.36M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 163.82M sh
Capex FY 2025 · Dec 31, 2025 $4.69M
Capex FY 2025 · Dec 31, 2024 $523K
Capex FY 2025 · Dec 31, 2023 $50K
Operating Cash Flow FY 2025 · Dec 31, 2025 $109.84M
Operating Cash Flow FY 2025 · Dec 31, 2024 $157.72M
Operating Cash Flow FY 2025 · Dec 31, 2023 $16.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $177.7M
Cash And Equivalents FY 2025 · Dec 31, 2024 $319.59M
Cash And Equivalents FY 2025 · Dec 31, 2023 $188.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.23B
Stockholders Equity FY 2025 · Dec 31, 2024 $732.79M
Stockholders Equity FY 2025 · Dec 31, 2023 $431.76M
Stockholders Equity FY 2025 · Dec 31, 2022 $400.41M
Current Liabilities FY 2025 · Dec 31, 2025 $277.11M
Current Liabilities FY 2025 · Dec 31, 2024 $394.87M
Total Liabilities FY 2025 · Dec 31, 2025 $336.81M
Total Liabilities FY 2025 · Dec 31, 2024 $454.96M
Current Assets FY 2025 · Dec 31, 2025 $1.06B
Current Assets FY 2025 · Dec 31, 2024 $938.32M
Total Assets FY 2025 · Dec 31, 2025 $1.56B
Total Assets FY 2025 · Dec 31, 2024 $1.19B
Eps Diluted FY 2025 · Dec 31, 2025 $2.30
Eps Diluted FY 2025 · Dec 31, 2024 $1.36
Eps Diluted FY 2025 · Dec 31, 2023 −$0.37
Eps Basic FY 2025 · Dec 31, 2025 $2.32
Eps Basic FY 2025 · Dec 31, 2024 $1.37
Eps Basic FY 2025 · Dec 31, 2023 −$0.37
Sga Expense FY 2025 · Dec 31, 2025 $548.89M
Sga Expense FY 2025 · Dec 31, 2024 $488.43M
Sga Expense FY 2025 · Dec 31, 2023 $406.56M
Rd Expense FY 2025 · Dec 31, 2025 $328.8M
Rd Expense FY 2025 · Dec 31, 2024 $303.25M
Rd Expense FY 2025 · Dec 31, 2023 $351.62M
Net Income FY 2025 · Dec 31, 2025 $391M
Net Income FY 2025 · Dec 31, 2024 $226.45M
Net Income FY 2025 · Dec 31, 2023 −$61.29M
Operating Income FY 2025 · Dec 31, 2025 $104.81M
Operating Income FY 2025 · Dec 31, 2024 $230.79M
Operating Income FY 2025 · Dec 31, 2023 −$73.38M
Cost Of Revenue FY 2025 · Dec 31, 2025 $89M
Cost Of Revenue FY 2025 · Dec 31, 2024 $81.84M
Cost Of Revenue FY 2025 · Dec 31, 2023 $41.64M
Revenue FY 2025 · Dec 31, 2025 $1.07B
Revenue FY 2025 · Dec 31, 2024 $957.8M
Revenue FY 2025 · Dec 31, 2023 $726.44M